T1	Participants 231 243	All patients
T2	Participants 107 229	A pilot study with adjuvant hormone therapy in FIGO stage I endometrial carcinoma with myometrial invasion was carried out
T3	Participants 665 676	62 patients
T4	Participants 798 885	Five patients had a relapse: four of these were in the group with no further treatment.
